NRx Pharmaceuticals, Inc. (NRXP) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 58M |
| Enterprise Value | 50.83M |
| P/E Ratio | -4.58 |
| PEG Ratio | -0.04 |
| Price/Sales Ratio | 17.32 |
| Price/Book Ratio | -752.99 |
| Enterprise/Revenue | 9.82 |
| Enterprise/EBITDA | -1.52 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -6.92 |
| Operating Margin | -5.88 |
AD
Management Effectiveness
| Return On Assets | -0.69 |
| Return On Equity | 1.69 |
Income Statement
| Revenue | 1.23M |
| Revenue/Share | 0.09 |
| Gross Profit | 720,000 |
| EBITDA | -27.81M |
| Net Income | -28.62M |
| Diluted EPS | -1.34 |
Balance Sheet
| Total Cash | 26.69M |
| Total Cash/Share | 0.71 |
| Total Debt | 1.25M |
| Total Debt/Equity | -7.33 |
| Current Ratio | 0.86 |
| Book Value Per Share | -0 |
Price History
| 52-Week Change | 21.43 |
| 52-Week High | 5.06 |
| 52-Week Low | 1.62 |
| Moving Average 50 Days | 3.65 |
| Moving Average 200 Days | 2.87 |
Statistics
| Average Volume | 938,668 |
| Shares Outstanding | 17.29M |
| % Held by Institutions | 30.91 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | April 02, 2024 |
AD
